The Economic Burden of End-Organ Damage Among Medicaid Patients with Sickle Cell Disease in the United States: A Population-Based Longitudinal Claims Study

BACKGROUND: The management of sickle cell disease (SCD), an inherited, chronic, and multifaceted condition, is associated with considerable health care resource utilization (HRU) and costs, especially for Medicaid. Anemia affects most patients with SCD and correlates with end-organ damage (EOD), suc...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, Andrew, Cong, Ze, Agodoa, Irene, Song, Xue, Martinez, Diane J., Black, Danae, Lew, Carolyn R., Varker, Helen, Chan, Chris, Lanzkron, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391152/
https://www.ncbi.nlm.nih.gov/pubmed/32597290
http://dx.doi.org/10.18553/jmcp.2020.20009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391152/
https://www.ncbi.nlm.nih.gov/pubmed/32597290
http://dx.doi.org/10.18553/jmcp.2020.20009

Ejemplares similares